Hawaiian Eye/Retina Meeting

Hawaiian Eye/Retina Meeting

January 27, 2019
1 min watch

VIDEO: EyePoint to launch two new products in first quarter

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAIKOLOA, Hawaii — Nancy Lurker, CEO of EyePoint Pharmaceuticals, discusses the planned launch of Yutiq (fluocinolone acetonide intravitreal implant 0.18 mg) for posterior segment uveitis and Dexycu (dexamethasone injectable suspension 9%) for postoperative inflammation following cataract surgery here at Hawaiian Eye 2019.